| Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model K Anthony-Gonda, A Bardhi, A Ray, N Flerin, M Li, W Chen, ... Science translational medicine 11 (504), eaav5685, 2019 | 131 | 2019 |
| Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein A Bardhi, Y Wu, W Chen, W Li, Z Zhu, JH Zheng, H Wong, E Jeng, J Jones, ... Journal of virology 91 (20), 10.1128/jvi. 00937-17, 2017 | 42 | 2017 |
| Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs NC Flerin, A Bardhi, JH Zheng, M Korom, J Folkvord, C Kovacs, E Benko, ... Journal of virology 93 (6), 10.1128/jvi. 02051-18, 2019 | 30 | 2019 |
| Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1 W Chen, A Bardhi, Y Feng, Y Wang, Q Qi, W Li, Z Zhu, MA Dyba, T Ying, ... MAbs 8 (4), 761-774, 2016 | 21 | 2016 |
| Rapid elimination of broadly neutralizing antibodies correlates with treatment failure in the acute phase of simian-human immunodeficiency virus infection Y Wu, J Xue, C Wang, W Li, L Wang, W Chen, P Prabakaran, D Kong, ... Journal of virology 93 (20), 10.1128/jvi. 01077-19, 2019 | 8 | 2019 |
| Targeting HIV Using Anti-HIV duoCAR-T Cell Therapy K Anthony-Gonda, A Bardhi, A Ray, Y Wang, W Krueger, D Schneider, ... MOLECULAR THERAPY 28 (4), 59-59, 2020 | | 2020 |
| Hacking the Immune System to Cure HIV-1: Potent Elimination of HIV-1-Infected Cells by Antibody Based Therapeutics A Bardhi Yeshiva University, 2018 | | 2018 |
